Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Control Trial of Bone Loading Exercises Versus Risedronate on Bone Health in Post-Menopausal Women
Brief Summary: The purpose of this study is to identify the best way to prevent bone loss in the first years after menopause. The HOPS study will compare bone loss at 12 months in women: 1) who take calcium and vitamin D only; 2) who take calcium and vitamin D plus the medication "risedronate"; or 3) who take calcium and vitamin D plus participate in bone-loading exercises. Our central hypothesis is that improvements in bone health will be greater in women randomized to bone-loading exercises with calcium and vitamin D compared to women who take calcium and vitamin D only or women who take calcium and vitamin D plus risedronate.


Options:
A: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Calcium Carbonate, Drug: Vitamin D3 | Arm Label: Risedronate; Type: EXPERIMENTAL; Interventions: Drug: Calcium Carbonate, Drug: Vitamin D3, Drug: Risedronate | Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Drug: Calcium Carbonate, Drug: Vitamin D3, Behavioral: Bone-loading exercises | Intervention Type: DRUG; Name: Calcium Carbonate; Assigned to Arm(s): Control, Exercise, Risedronate | Intervention Type: DRUG; Name: Vitamin D3; Assigned to Arm(s): Control, Exercise, Risedronate | Intervention Type: DRUG; Name: Risedronate; Assigned to Arm(s): Risedronate | Intervention Type: BEHAVIORAL; Name: Bone-loading exercises; Assigned to Arm(s): Exercise
B: Arm Label: Genistein vs. Risedronate; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Genistein vs Risedronate | Arm Label: Genistein dose and source; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Genistein vs Risedronate | Intervention Type: DIETARY_SUPPLEMENT; Name: Genistein vs Risedronate; Assigned to Arm(s): Genistein dose and source, Genistein vs. Risedronate
C: Arm Label: Alendronate 70 mg; Type: EXPERIMENTAL; Interventions: Drug: Alendronate, Dietary Supplement: Elemental Calcium, Dietary Supplement: Vitamin D, Drug: Risendronate placebo | Arm Label: Risendronate 35 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Risedronate 35 mg, Dietary Supplement: Elemental Calcium, Dietary Supplement: Vitamin D, Drug: Alendronate placebo | Intervention Type: DRUG; Name: Alendronate; Assigned to Arm(s): Alendronate 70 mg | Intervention Type: DRUG; Name: Risedronate 35 mg; Assigned to Arm(s): Risendronate 35 mg | Intervention Type: DIETARY_SUPPLEMENT; Name: Elemental Calcium; Assigned to Arm(s): Alendronate 70 mg, Risendronate 35 mg | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D; Assigned to Arm(s): Alendronate 70 mg, Risendronate 35 mg | Intervention Type: DRUG; Name: Risendronate placebo; Assigned to Arm(s): Alendronate 70 mg | Intervention Type: DRUG; Name: Alendronate placebo; Assigned to Arm(s): Risendronate 35 mg
D: Arm Label: Teriparatide; Type: EXPERIMENTAL; Interventions: Drug: Teriparatide, Drug: Placebo, Drug: Calcium, Drug: Vitamin D | Arm Label: Risedronate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Risedronate, Drug: Placebo, Drug: Calcium, Drug: Vitamin D | Intervention Type: DRUG; Name: Teriparatide; Assigned to Arm(s): Teriparatide | Intervention Type: DRUG; Name: Risedronate; Assigned to Arm(s): Risedronate | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Risedronate, Teriparatide | Intervention Type: DRUG; Name: Calcium; Assigned to Arm(s): Risedronate, Teriparatide | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): Risedronate, Teriparatide

Answer: A